https://www.selleckchem.com/pr....oducts/ch5424802.htm
The surgical success rate at six months postoperatively was not different between the Oloxen and Xen groups (56.4% vs 43.3%, P 0.05) or between the Phaco-Oloxen group and PhacoXen group (57.9% vs 41.7%, P 0.05). The prevalence of postoperative hypotony, 5-fluorouracil injections, use of anti-glaucoma medications, bleb needling, and additional glaucoma surgeries was not different between the Oloxen and Xen groups or between the Phaco-Oloxen and PhacoXen groups when assessed six months postoperatively. All groups showed signif
Like
Comment
Share
